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Summary: Commercial control sera contain varying amounts of pyridoxal-5'-phosphate. Normalization of
aminotransferase activity measurement with enzyme'standards' is possible only when pyridoxal-5'-phosphate
is added to the reaction medium.
Pyridoxal-5'-phosphate addition should be compulsory in national recommendations.
%
Schwierigkeiten bei der Kalibrierung von Bestimmungen der Aminotransferasen mit Enzymstandards
Zusammenfassung: Käufliche Kontrollseren enthalten unterschiedliche Konzentrationen von Pyridoxal-5'-
phosphat. Eine Normalisierung der Aminotransferase-Aktivitätsmessung mit Enzym'standards' ist nur mög-
lich unter Zugabe von Pyridoxal-5'-phosphat zum Reaktionsmedium.
Pyridoxal-5'-phosphat-Zugabe sollte in nationalen Empfehlungen obligatorisch sein.
Introduction
In our work on enzyme Standards we encountered
difficulties in the determination of aspartate amino-
transferase (l, 2). In contiast to the favourable effect
of enzyme Standards on the results of other enzyme
determinations, the use of Standards conferred no
benefit in the determination of aspartate amino-
transferase. This seemed to be due to deficiencies in
the reaction medium. In several methods and recom-
mendations, pyridoxaUS'^phosphate is not added to
the reaction medium. The old thesis was therefore
adopted that pyridoxal-S'^phosphate is necessary for
optimal aspartate amiriotfansferase catalytic activity;
at the same time it was thought that the pyridoxal·
5'-phosphate content of various control sera and
Standards is subject to considerable variations.
Methods not including pyridoxal-S'-phosphate in the
reaction medium would therefore give different re^
sults for serum and Standard, compared with methods
that include additional pyridoxal-5'-phosphate in the
reaction medium. If a serum or Standard already
contains sufficient pyridoxal-S'-phosphate, then the
addition of more pyridoxal-S'-phosphate will have no
effect, but when a serum or Standard is deficient in
pyridoxal-S'-phosphate the addition of the coenzyme
will alter the results.
Although many national recommendations for aspar-
tate aminotransferase measurement include pyri-
doxal-S'-phosphate, addition of the cofactor is not
obligatory in the German and Scandinavian recom-
mendations. In the Scandinavian recommendations
of 1974 (9) a possible supplementation with pyri-
doxal-S'-phosphate was suggested especially for
aspartate aminotransferase. Special mention was
made in that publication of the lack of pyridoxal
phosphate in most commercial control sera. The use
of pyridoxal-S'-phosphate is therefore not so seif
evident, not even in the Netherlands, where 48% of
the laboratories do no include it in the reaction me-
dium for aspartate aminotransferase determination,
despite strong evidence in the literature (3 — 6) of the
activating effect of pyridoxal-5x-phosphate on amino-
transferase.
for enzymes in the Netherlands Quality Assessment
Programme for clinical chemical hospital labora-
tories, it is now possible to discriminate for
temperature and also, äs far äs the aminotransferases
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are concerned, for addition of pyridoxal-5'-phos-
phate.
The problem of the enzyme Standard in aspartate
aminotransferase determinations has been in-
vestigated in a trial of the coupled external/internal
program (7) and also in the external scheme.
It was thought worthwhile to call attention once more
to the problem of pyridoxal-5'-phosphate sup-
plementation of reaction media for the measurement
of aminotransferase catalytic activity, especially for
the normalization of enzyme determination with Stan-
dards.
Materials and Methode
In the coupled external/internal programme some 70 lab*
oratories analysed, over a period of 40 days, Precinorm U, a
bovine serum from Boehringer Mannheim lot no Ch 1-501.
Omega, a human serum from Hyland, Travenol, lot no 4833
Υ 005 ΒΑ was used and considered s the enzyme "Standard1 in
this trial, although the material in facit is not a Standard.
In table l the codes are given for the different methods used.
The pyridox l-5'-phosphate of serum and Standard was meas-
ured according to the methpd described by Westerhuis &
Hajkenscheid (8). In the external quality assessment Pro-
gramme, 4 sera were used for this i vestigation. Sera I and II
are human sera (Ortho, lot n s. X39Y02B and X40Y02B).
Serum ΙΠ is a horse serum and serum IV is of human origin
(Netherlands Institute of Public Health).
Tab. l. Method codes for aspartate (ASAT) and alanine aminotransferase (ALAT) determinations.
Code
ASAT
120
121
122
123
124
125
126
127
128
129
620
621
622
623
624
625
626
627
628
629
v , ALAT
130
131
132
133
134
135
136
137
138
139
630
631
632
633
634
635
636
637
638
639
Method
manual
automated
manual
automated
manual
automated
centrifugal analyser
centrifugal analyser
manual
automated
manual
automated
manual
automated
manual
automated
manual
automated
manual
automated
Buffer
tris
tris
tris
tris
phosphate
phosphate
phosphate
tris
tris
tris
tris
tris
phosphate
phosphate
tris
tris
tris
tris
phosphate
phosphate
Temperature
(°C)
25
25
25
25
25
25
25
30
30
30
30
30
30
30
37
37
37
37
37
37
Pyridoxal- Reference
5'-phosphate
added
yes
yes
no
no
no 10
np 10
no 10
yes 11'
yes 11
yes 11
no
no
no
no
yes.
yes
no
no
no
no
Tab. 2. Catalytic concentrations of aspartate aminotransferase in U/l in Omega and Boehringer sera. n is the number of
participating laboratories. The result per laboratory is the mean of 40 independently perfprmed analyses. Results from
internal/external scheme.
Method
122
124
125
127
128
129
621
623
626
627
629
Boehringer
n
1
5
4
29
1
18
2
2
1
3
2
serum
mean
81.4
50.5
38.2
49.8
50.8
49.9
49.0
55.4
60.1
73.9
86.9
Omega
n
1
4
4
25
1
18
2
1
1
2
2
serum
mean
50.8
42.3
26.5
45.4
50.2
43.3
32.0
29.6
33.0
43.9
58.6
Ratio
1.60
1.20
1.44
1.10
1.01
1.14
1.53
1.87
1,82
1.68
1.48
Pyridoxal-
5'-phosphate
added
no
no
no
yes
yes
yes
no
no
no
no
no
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Results
In table 2 the results are presented for the different
methods used in the determination of aspartate
aminotransferase with the Boehringer and Omega
material. It should be remembered that the result of
each laboratory is the average of 40 measurements
on different days, so even method results obtained
with few laboratories are relevant. In table 3 results
are compared for aspartate aminotransferase and
alanine aminotransferase measurement by similar
methods with and without pyridoxal-5'-phosphate
addition. The pyridoxal-5'-phosphate content of the
sera is given in table 4. In table 5 data are presented
from two trials of the extern l quality assessment
Programme.
Statistical evaluation
Table 5 shows a comparison of results obtained at the
same temperature, but in the presence and absence of
pyridoxal-S'-phosphate (Studenfs t-test).
Tab. 4. Pyridoxal-5'-phosphate content of 6 sera used in this
investigation. Serum III and IV were made available
by RIVM (Netherlands Institute of Public Health).
Pyridoxal-
S'-phosphate
Omega
Boehringer
Serum I Ortho
Serum II Ortho
Serum III
Serum IV
2.9
110
11.5
9.5
108
156
For aspartate aminotransferase, the results obtained
with methods 127, 128 and 129 are similar (p > 0.8)
for both sera I and II.
Results obtained with methods 621 and 128 are not
similar (p < 0.001).
The same holds for results found with methods 121
and 123 (p < 0.001) and methods 624 and 627
(p < 0.001).
Tab. 3. Comparison of aspartate (ASAT) and alanine aminotransferase (ALAT) results in U/l with identical methods, with the
exception of pyridoxal-5'-phosphate addition (P-5'-P) to the medium. Results from internal/external scheme.
Method
Centrifugal fast analyser
Automated
Automated
Tem-
peratur
30
30
30
Buffer
e
tris
tris
tris
P-5'-P
yes
yes
no
Boehringer
ASAT
49.8
49.9
49.0
ALAT
42.2
40.8
39.8
Omega
ASAT
45.4
43.3
32.0
ALAT
28.9
29.8
26.1
Tab. 5. Aminotransferase results in U/l from the Netherlands extern l quality assessment programme. Serum I, II and IV are of
human origin, serum III is horse serum. PyridoxaI-5'-phosphate was added (100 μg/l) to sera III and IV.
Method
code
Pyridoxal-
5'-phosphate
added
Tem-
perature
(°C)
Serum I
n χ ± s
Serum
n X
II
± s
Serum III
n χ ± s
Serum IV
n χ ± s
Aspartate aminotransferase
127
128
129
621
121
123
624
627
yes
yes
yes
no
yes
no
yes
no
30
30
30
30
25
25
37
37
28
5
30
3
3
4
3
11
69.3
69.4
68.5
39.7
40.7
27.8
74.0
59.5
±
+
±
±
±
±
±
±
3.9
1.7
4.2
0.6
2.9
1.0
4.6
1.8
43
7
30
4
3
6
3
10
173.6
178.7
176.5
103.5
111.0
71.8
196.3
159.4
±
±
±
±
±
±
±
±
23.2
9.8
14.5
6.5
11.0
6.6
11.0
7.3
42
7
36
4
171.0
170.4
167.4
169.5
10.3
17.1
7.4
1.3
37
6
40
5
25.2 ± 2.3
25.2 ± 1.5
26.0 ± 2.9
28.8 ± 1.9
Alanine aminotransferase
137
138
139
631
131
133
634
637
yes
yes
yes
no
yes
no
yes
no
30
30
30
30
25
25
37
37
34
26
34
5
4
5
3
9
29.6 ± 3.6
30.8 + 3.3
30.4 + 2.6
25.2 ± 1.1
23.5 ± 5.3
17.8 ± 1.9
33.0 ± 6.2
34.7 ± 1.6
30
18
33
4
4
6
3
11
101.9 ±
95.9 ±
97.9 ±
89.5 ±
78.3 ±
55.0 ±
113.0 ±
116.6 ±
8.6
3.3
6.7
3.4
17.7
8.4
14.1
6.3
36
22
33
5
42.8 ± 3.6
44.6 + 4.8
43.3 + 2.8
41.6 ± 2.6
36
23
40
4
14.7 ± 1.9
16.0 + 2.2
15.6 ± 2.5
16.8 ± 1.0
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For alanine aminotransferase, the results obtained
with methods 127, 128 and 129 on the one side differ
significantly from those of method 621 (p < 0.01).
The differences between methods 121 and 123 are
significant at the 5% level (p < 0.05).
No significant differences were observed between
results with method 624 and 627 (p < 0.2).
Tested for the F-distribution the variances were con-
sidered equal (p < 0.95).
Discussion and Conclusions
From table2 it is obvious that 70% of the lab-
oratories participating in the coupled external/
internal programme use the aspartate amino-
transferase method recommended by the NVKC
(Netherlands Society for Clinical Chemistry). In con-
trast to this finding in the external programme, only
47% of thek participants use the recommended
method for aspartate aminotransferase, in which
pyridoxal-5'-phosphate is added. It is also obvious
that the ratio of Boehringer/Omega results is higher
when pyridoxal-5'-phosphate is omitted than when it
is included.
Consideration of table 3 and 4 makes it clear why
the use of a Standard not always improves the results
of aspartate aminotransferase.
When the pyridoxal-5'-phosphate content of a sample
is low, the differences in analytical results between
methods including or omitting pyridoxal-5'-phos-
phate become obvious. However, when the sample
does contain a considerable amount of pyridoxal-5'-
phosphate these differences are eliminated.
Table 3 also shows the results for alanine amino-
transferase, which demonstrate that pyridoxal-5'-
phosphate activation of alaninef aminotransferase is
smaller than for aspartate aminotransferase.
Data from the external trials presented in table 5
confirm the Statements made above. Again dif-
ferences in aspartate aminotransferase results occur
for different methods when the pyridoxal-5'-phos-
phate content of seruni is low (tab. 5). The effect is
demonstrated for different ternperatures (serum I and
II). In table 5 results are also giveri for sera containing
considerable amounts of pyridoxal-S'-phosphate, arid
it can be seen that methodological effects then dis-
appear (serum HI and IV).
Too few data were available to show the effects for
temperatures other than 30°C.
These findings seem to contrast with data from the
literature (6, 8), which report similär seiisitivity
towards pyridoxal-5'-phosphate for both aspartate
and alanine aminotransferase activity measurements.
In conclusion it can be stated that recommendations
for aminotransferase catalytic activity measurement
should include pyridoxal-S'-phosphate in the reaction
medium to optimize specificity. Manufacturers of
control sera should be advised to add pyridoxal^S'-
phosphate to these sera (50 g/l) in order to achieVe
comparable analytical resuhs with optimized and
deficient methods.
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